Acorda Therapeutics (26) | Business Finance (9)
Browse by Subcategory
Recent Contracts
-
Form of stock option certificate under the Acorda Therapeutics 2016 Inducement Plan
(Filed With SEC on March 18, 2022)
-
Asset Purchase Agreement, dated as of January 12, 2021, between the Registrant and Catalent Pharma Solutions, Inc
(Filed With SEC on March 16, 2021)
-
Form of Exchange Agent Agreement, dated as of December 20, 2019, among the Company, the guarantors party thereto, and the holder named therein
(Filed With SEC on December 26, 2019)
-
Security Agreement, dated as of December 23, 2019, from the grantors named therein to Wilmington Trust, National Association, as collateral agent
(Filed With SEC on December 26, 2019)
-
Registration Rights Agreement, dated as of December 20, 2019, among the Company and the investors party thereto
(Filed With SEC on December 26, 2019)
-
Indenture, dated as of December 23, 2019, among the Company, the guarantors party thereto, and Wilmington Trust, National Association, as trustee and collateral agent
(Filed With SEC on December 26, 2019)
-
Description of Common Stock
(Filed With SEC on March 16, 2021)
-
Specimen stock certificate evidencing shares of common stock
(Filed With SEC on March 16, 2021)
-
Description of Common Stock
(Filed With SEC on February 28, 2020)